As a medical technology journalist, a little more than a decade ago I found myself sitting in those late afternoon ...
Structural Heart Occluders
This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex
April 21, 2021
April 20, 2021 — Start-up medical device company atHeart Medical announced it is initiating its U.S. investigational ...
April 20, 2021
Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial, and ...
March 23, 2021
Feature | Hemostasis Management | Dave Fornell, Editor
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...
March 09, 2021
October 16, 2020 — Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage ...
October 16, 2020
October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial ...
October 15, 2020
August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...
August 21, 2020
August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...
August 06, 2020
Devi G. Nair, M.D., FHRS, director of cardiac electrophysiology, St. Bernards Heart and Vascular Center, Jonesboro, Ark ...
July 24, 2020
July 22, 2020 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman ...
July 22, 2020
July 1, 2020 — Carag AG announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption ...
July 01, 2020
Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...
May 22, 2020
Interview with Carey Kimmelstiel, M.D., FACP, FACC, director, cardiac catheterization laboratory, director ...
March 24, 2020
Charles D. Resor, M.D., MSc, assistant director, cardiac catheterization lab, Tufts Medical Center and assistant ...
February 27, 2020
February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess ...
February 03, 2020© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now